retatrutide lancet New GLP-3 drug significantly slashes both weight and blood sugar levels in Phase III trial The Lancet study unveils exciting

A dual agonist activates two incretin receptors (tirzepatide: GIP + GLP-1)

Blood pressure improvements appear early in treatment

Approval (Most Likely): FDA issues approval letter

The 2.0mL option at 10mg/mL still works for the 4-8mg range but becomes impractical for 12mg doses since you would need to draw 120 units, which exceeds the capacity of a standard 100-unit insulin syringe

Tirzepatide dry mouth profile Tirzepatide, marketed as Mounjaro and Zepbound, shows a reporting-odds ratio of 1.35 for dry mouth, marginally higher than semaglutide

You may not republish our articles behind a paywall or in publications whose primary purpose is advertising or product promotion